UBS cuts target for Healthcare Realty Trust stock to USD 18.00
Published on 10/15/2026 at 20:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUBS target and reporting date
- UBS lowered its Healthcare Realty Trust target to USD 18.00 on October 13, 2026.
- Adjusted quarterly earnings per share were negative USD 0.13 in the second quarter of 2026.
- Healthcare Realty stock costs EUR 15.35 at Lang & Schwarz on October 15, 2026 at 8:39 p.m. CEST.
- Healthcare Realty Trust is scheduled to report third-quarter results on October 29, 2026.
UBS lowered its price target for Healthcare Realty Trust from USD 21.00 to USD 18.00 on October 13, 2026, while maintaining a Neutral rating, according to MarketBeat. The revised target is USD 18.00, or 4.35 percent above the primary-exchange price of USD 17.25 at the latest October 15, 2026 quote.
Healthcare Realty Trust stock was trading at EUR 15.35 at Lang & Schwarz on October 15, 2026 at 8:39 p.m. CEST. The euro quotation is an after-hours indication for investors in Germany.
Second-quarter earnings set the baseline
Healthcare Realty Trust reported revenue of USD 278.58 million for the second quarter of 2026, while net income attributable to common shareholders was negative USD 43.51 million. Diluted earnings per share were negative USD 0.13 for the period, according to MarketBeat. Revenue exceeded the cited consensus estimate of USD 271.60 million, but the earnings result fell short of the USD 0.40 estimate.
Stock position and valuation
The latest primary-exchange quote was USD 17.25 on October 15, 2026 at 2:43 p.m. EDT on the NYSE. Healthcare Realty Trust had a 52-week range of USD 16.31 to USD 22.04, placing the quote USD 0.94 above the low and USD 4.79 below the high. Its market capitalization was USD 6.0 billion, and its trailing price-to-earnings ratio was negative 65.78.
What comes next for results
Quiver Quantitative reported that Healthcare Realty Trust is scheduled to release its third-quarter 2026 results on October 29, 2026, after the market closes. The company scheduled its earnings call for October 30, 2026, at 9:00 a.m. Eastern Time. The upcoming report will give investors a fresh comparison with the second-quarter loss and revenue level.
Comparison with peers
Healthcare Realty Trust (NYSE, USD): P/E negative 65.78, market capitalization USD 6.0 billion
Healthpeak Properties (NYSE, USD): plus 1.04 percent, P/E 54.13, market capitalization USD 13.1 billion
Welltower (NYSE, USD): plus 0.96 percent, P/E 124.05, market capitalization USD 168.9 billion
Investor reference points
The analyst revision and the upcoming reporting date create two clear reference points for the stock. UBS now places its target at USD 18.00, while the latest primary-exchange quote was USD 17.25. The company also enters the next earnings release with second-quarter revenue of USD 278.58 million and negative diluted earnings per share of USD 0.13.
Healthcare Realty Trust stock was trading at EUR 15.35 at Lang & Schwarz on October 15, 2026 at 8:39 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Healthcare Realty Trust stock.
Healthcare Realty Trust market data
- Company: Healthcare Realty Trust Incorporated
- ISIN: US42226K1051
- Ticker: HR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 8:39 p.m. CEST): EUR 15.35
- Market capitalization: USD 6.0 billion (as of October 15, 2026)
- 52-week range: USD 16.31-22.04 (as of October 15, 2026)
- Sector / Industry: Real Estate / Equity REITs
Market context: Market report S&P 500.
